Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells

Detalles Bibliográficos
Autores principales: Stefka, A T, Park, J-H, Matsuo, Y, Chung, S, Nakamura, Y, Jakubowiak, A J, Rosebeck, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022182/
https://www.ncbi.nlm.nih.gov/pubmed/27540718
http://dx.doi.org/10.1038/bcj.2016.71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022182/
https://www.ncbi.nlm.nih.gov/pubmed/27540718
http://dx.doi.org/10.1038/bcj.2016.71

Ejemplares similares